Visceral adiposity and left ventricular mass and function in patients with aortic stenosis: The PROGRESSA study

Canadian Journal of Cardiology

Volumn 30, Issue 9, 2014, Pages 1080-1087

  Capoulade, Romain ^a   Larose, Éric ^a   Mathieu, Patrick ^a   Clavel, Marie Annick ^a   Dahou, Abdellaziz ^a   Arsenault, Marie ^a   Bédard, Élisabeth ^a   Larue Grondin, Samuel ^a   Le Ven, Florent ^a   Dumesnil, Jean G ^a   Després, Jean Pierre ^a   Pibarot, Philippe ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; AGED; AORTA STENOSIS; ARTICLE; BODY FAT DISTRIBUTION; BODY MASS; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; OBESITY; PROSPECTIVE STUDY; SUBCUTANEOUS FAT; SYSTOLIC DYSFUNCTION;

ADIPOSE TISSUE; AGED; AORTIC VALVE STENOSIS; BODY MASS INDEX; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; HEART VENTRICLES; HUMANS; MALE; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; SUBCUTANEOUS FAT; TOMOGRAPHY, X-RAY COMPUTED; VENTRICULAR DYSFUNCTION, LEFT; VISCERA;

EID: 84906313233     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2014.02.007     Document Type: Article

References (31)

1. Dumesnil J.G., Shoucri R.M. Effect of the geometry of the left ventricle on the calculation of ejection fraction. Circulation 1982, 65:91-98.
2. Greve A.M., Boman K., Gohlke-Baerwolf C., et al. Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study. Circulation 2012, 125:346-353.
3. Cioffi G., Faggiano P., Vizzardi E., et al. Prognostic value of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011, 97:301-307.
4. Holme I., Pedersen T.R., Boman K., et al. Arisk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis. Heart 2012, 98:377-383.
5. Duncan A.I., Lowe B.S., Garcia M.J., et al. Influence of concentric left ventricular remodeling on early mortality after aortic valve replacement. Ann Thorac Surg 2008, 85:2030-2039.
6. Lund B.P., Gohlke-Barwolf C., Cramariuc D., et al. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). Am J Cardiol 2010, 105:1456-1460.
7. Pagé A., Dumesnil J.G., Clavel M.A., et al. Metabolic syndrome is associated with more pronounced impairment of LV geometry and function in patients with calcific aortic stenosis: A substudy of the ASTRONOMER trial. (Aortic Stenosis Progression Observation Measuring Effects of Rosuvastatin). JAm Coll Cardiol 2010, 55:1867-1874.
8. Capoulade R., Clavel M.A., Dumesnil J.G., et al. Insulin resistance and LVH progression in patients with calcific aortic stenosis: a substudy of the ASTRONOMER trial. JACC Cardiovasc Imaging 2013, 6:165-174.
9. Lindman B.R., Arnold S.V., Madrazo J.A., et al. The adverse impact of diabetes mellitus on left ventricular remodeling and function in patients with severe aortic stenosis. Circ Heart Fail 2011, 4:286-292.
10. Aurigemma G.P., Silver K.H., McLaughlin M., Mauser J., Gaasch W.H. Impact of chamber geometry and gender on left ventricular systolic function in patients over 60 years of age with aortic stenosis. Am J Cardiol 1994, 74:794-798.
11. Collis T., Devereux R.B., Roman M.J., et al. Relations of stroke volume and cardiac output to body composition. The strong heart study. Circulation 2001, 103:820-825.
12. Despres J.P., Lemieux I., Bergeron J., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
13. Mathieu P., Poirier P., Pibarot P., Lemieux I., Despres J.P. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009, 53:577-584.
14. Sharma N., Okere I.C., Duda M.K., et al. Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy. Cardiovasc Res 2007, 73:257-268.
15. Djousse L., Benkeser D., Arnold A., et al. Plasma free fatty acids and risk of heart failure: the Cardiovascular Health Study. Circ Heart Fail 2013, 6:964-969.
16. Dumesnil J.G., Shoucri R.M., Laurenceau J.L., Turcot J. Amathematical model of the dynamic geometry of the intact left ventricle and its application to clinical data. Circulation 1979, 59:1024-1034.
17. Lancellotti P., Donal E., Magne J., et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart 2010, 96:1364-1371.
18. Ng A.C., Delgado V., Bertini M., et al. Alterations in multidirectional myocardial functions in patients with aortic stenosis and preserved ejection fraction: a two-dimensional speckle tracking analysis. Eur Heart J 2011, 32:1542-1550.
19. Cramariuc D., Gerdts E., Davidsen E.S., Segadal L., Matre K. Myocardial deformation in aortic valve stenosis - relation to left ventricular geometry. Heart 2009, 96:106-112.
20. Lafitte S., Perlant M., Reant P., et al. Impact of impaired myocardial deformations on exercise tolerance and prognosis in patients with asymptomatic aortic stenosis. Eur J Echocardiogr 2009, 10:414-419.
21. Zhang L., Jaswal J.S., Ussher J.R., et al. Cardiac insulin resistance and decrease mitochondrial energy production precede the development of systolic heart failure following pressure overload hypertrophy. Circ Heart Fail 2013, 6:1039-1048.
22. Mahmod F., Bull S., Suttie J.J., et al. Myocardial steatosis and left ventricular contractile dysfunction in patients with severe aortic stenosis. Circ Cardiovasc Imaging 2013, 6:808-816.
23. Mathieu P., Pibarot P., Larose E., et al. Visceral obesity and the heart. Int J Biochem Cell Biol 2008, 40:821-836.
24. Marfella R., Di Filippo C., Portoghese M., et al. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. JLipid Res 2009, 50:2314-2323.
25. Poirier P., Giles T.D., Bray G.A., et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 2006, 113:898-918.
26. Lemieux I., Pascot A., Couillard C., et al. Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?. Circulation 2000, 102:179-184.
27. Despres J.P. Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012, 126:1301-1313.
28. Katz R., Wong N.D., Kronmal R., et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation 2006, 113:2113-2119.
29. Katz R., Budoff M.J., Takasu J., et al. Relationship of metabolic syndrome to incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes 2009, 58:813-819.
30. Capoulade R., Clavel M.A., Dumesnil J.G., et al. Impact of metabolic syndrome on progression of aortic stenosis: influence of age and statin therapy. JAm Coll Cardiol 2012, 60:216-223.
31. Briand M., Pibarot P., Despres J.P., et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation 2006, 114:I512-I517.